Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Medtronic
MDT
|
$580M |
| 2 |
Citigroup
C
|
$486M |
| 3 |
Cimpress
CMPR
|
$398M |
| 4 |
Broadcom
AVGO
|
$367M |
| 5 |
Apple
AAPL
|
$285M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
$348M |
| 2 |
Microsoft
MSFT
|
$337M |
| 3 |
IQVIA
IQV
|
$249M |
| 4 |
Costco
COST
|
$202M |
| 5 |
AbbVie
ABBV
|
$177M |
Sector Composition
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.75% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Revvity
RVTY
$10.5B
| $425M | 0.27% | 6,161,489 -244,187 | -4% | -$16.8M |
|
102
MSCI
MSCI
$43.9B
| $420M | 0.27% | 3,594,478 -200,146 | -5% | -$23.4M |
|
103
Air Products & Chemicals
APD
$65.5B
| $420M | 0.27% | 2,774,243 +54,048 | +2% | +$8.17M |
|
104
Verisk Analytics
VRSK
$37.5B
| $418M | 0.27% | 5,024,212 -478,635 | -9% | -$39.8M |
|
105
HEICO Class A
HEI.A
$34.1B
| $414M | 0.27% | 5,433,090 -221,230 | -4% | -$16.9M |
|
106
Belden
BDC
$5.16B
| $409M | 0.26% | 5,072,653 +174,365 | +4% | +$14M |
|
107
Nice
NICE
$8.73B
| $407M | 0.26% | 5,006,620 -44,123 | -0.9% | -$3.59M |
|
|
108
Cimpress
CMPR
$1.55B
| $398M | 0.26% | +4,079,832 | New | +$398M |
|
109
PepsiCo
PEP
$204B
| $398M | 0.25% | 3,567,586 +659,663 | +23% | +$73.5M |
|
110
Pfizer
PFE
$141B
| $396M | 0.25% | 11,101,713 -2,073,474 | -16% | -$74M |
|
111
Procter & Gamble
PG
$368B
| $392M | 0.25% | 4,305,492 -195,072 | -4% | -$17.7M |
|
112
Automatic Data Processing
ADP
$123B
| $390M | 0.25% | 3,563,824 -450,041 | -11% | -$49.2M |
|
113
Thermo Fisher Scientific
TMO
$186B
| $377M | 0.24% | 1,993,597 -348,449 | -15% | -$65.9M |
|
114
Zoetis
ZTS
$69.3B
| $376M | 0.24% | 5,893,853 +84,767 | +1% | +$5.4M |
|
115
3M
MMM
$82.8B
| $376M | 0.24% | 1,789,043 +442,061 | +33% | +$92.8M |
|
116
Cisco
CSCO
$274B
| $373M | 0.24% | 11,102,708 -2,425,351 | -18% | -$81.6M |
|
117
Ametek
AME
$42.7B
| $372M | 0.24% | 5,639,602 -764,068 | -12% | -$50.5M |
|
|
118
IQVIA
IQV
$32.4B
| $372M | 0.24% | 3,909,348 -2,622,509 | -40% | -$249M |
|
119
Charles Schwab
SCHW
$174B
| $370M | 0.24% | 8,463,696 -894,040 | -10% | -$39.1M |
|
120
Philip Morris
PM
$260B
| $370M | 0.24% | 3,328,836 +1,541,007 | +86% | +$171M |
|
121
Waste Management
WM
$91.2B
| $367M | 0.24% | 4,684,275 +366,450 | +8% | +$28.7M |
|
122
Zurn Elkay Water Solutions
ZWS
$7.6B
| $360M | 0.23% | 14,177,506 +738,129 | +5% | +$18.8M |
|
|
VAR
123
DELISTED
Varian Medical Systems, Inc.
VAR
| $354M | 0.23% | 3,538,817 -215,910 | -6% | -$21.6M |
|
124
Ryanair
RYAAY
$33.7B
| $353M | 0.23% | 3,344,656 -62,171 | -2% | -$6.55M |
|
125
Waters Corp
WAT
$18B
| $352M | 0.23% | 1,959,850 +30,057 | +2% | +$5.4M |
|